Invesco
TYRA icon

Invesco’s Tyra Biosciences TYRA Stock Holding History

Invesco’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$795K Sell
24,893
-84,159
-77% -$2.78M ﹤0.01% 3035
2026
Q1 		$4.18M Sell
109,052
-20,383
-16% -$660K ﹤0.01% 2266
2025
Q4 		$3.4M Buy
129,435
+113,925
+735% +$2.09M ﹤0.01% 2410
2025
Q3 		$217K Buy
+15,510
New +$177K ﹤0.01% 3542

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Invesco's TYRA Position: Q2 2026 in Review

Invesco reduced its Tyra Biosciences (TYRA) stake by 77% in Q2 2026, selling an estimated $2.78M and leaving 24,893 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

Invesco first reported a position in TYRA in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.18M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Invesco held 24,893 shares of Tyra Biosciences worth $795K as of Q2 2026.
  • Invesco sold 84,159 Tyra Biosciences shares in Q2 2026, an estimated $2.78M.
  • Tyra Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3035 holding.
  • Invesco first reported a position in Tyra Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Invesco's Tyra Biosciences position peaked at $4.18M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.